Filing Details
- Accession Number:
- 0000897069-25-001217
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2025-07-28 16:30:16
- Reporting Period:
- 2025-07-24
- Filing Date:
- 2025-07-28
- Accepted Time:
- 2025-07-28 16:30:16
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1533743 | Processa Pharmaceuticals Inc. | PCSA | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1308105 | Russell Skibsted | C/O Processa Pharmaceuticals, Inc. 601 21St Street Suite 300 Vero Beach FL 32960 | Chief Financial Officer | No | No | No | No |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Restricted Stock Units | Acquisiton | 2025-07-24 | 1,775,044 | $0.00 | 1,775,044 | $0.00 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 1,803,044 | No | 4 | A | Direct |
Footnotes
- Restricted stock granted under the Processa Pharmaceuticals, Inc. 2019 Omnibus Incentive Plan ("Omnibus Plan"), of which 1,753,212 shares are subject to stockholder approval of the revised Omnibus Plan.
- Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock, following its vesting on of one-third on January 1, 2026, and one-thirty-sixth each month thereafter until fully vested on January 1, 2028.
Billionaire Hedge Funds
